Shobhana Natarajan

Director - Rare Disease, Medical Affairs Biogen

Seminars

Thursday 16th July 2026
Roundtable: Securing Buy-In, Funding, & Guardrails in Risk-Averse Organizations
3:00 pm
  • Navigating leadership concerns around regulatory, reputational, and approval risk
  • Making the business and ethical case for EAP investment pre-approval
  • Designing guardrails that protect programs without stalling access
Shobhana Natarajan, Director, Rare Disease, Medical Affairs